Results 101 to 110 of about 34,455 (228)

Discovery of Ruthenium(II) Metallocompound and Olaparib Synergy for Cancer Combination Therapy. [PDF]

open access: yesJ Med Chem, 2023
Yusoh NA   +9 more
europepmc   +1 more source

Cloud BI: Future of Business Intelligence in the Cloud [PDF]

open access: yesarXiv, 2019
Cloud computing is gradually gaining popularity among businesses due to its distinct advantages over self-hosted IT infrastructures. Business Intelligence (BI) is a highly resource intensive system requiring large-scale parallel processing and significant storage capacities to host data warehouses. In self-hosted environments it was feared that BI will
arxiv  

Oxidized mC modulates synthetic lethality to PARP inhibitors for the treatment of leukemia. [PDF]

open access: yesCell Rep, 2023
Brabson JP   +25 more
europepmc   +1 more source

An adaptive peer-to-peer network for distributed caching of OLAP results [PDF]

open access: green, 2002
Panos Kalnis   +4 more
openalex   +1 more source

Подходы и проблемы обмена данными между информационными системами

open access: yesВестник КазНУ. Серия математика, механика, информатика, 2017
Обмен данными между двумя и более информационными системами всегда являлся актуальной и сложной задачей. За последние три десятилетия данная задача прошла свой эволюционный путь от ручного способа обмена до возможности автоматического обмена данными ...
M. B. Gabbassov, T. D. Kuanov
doaj  

Supporting Dimension Updates in an OLAP Server [PDF]

open access: bronze, 2002
Alejandro Vaisman   +3 more
openalex   +1 more source

Solutions for decision support in university management [PDF]

open access: yes
The paper proposes an overview of decision support systems in order to define the role of a system to assist decision in university management. The authors present new technologies and the basic concepts of multidimensional data analysis using models of ...
Andrei STANCIU   +3 more
core  

Temozolomide Sensitizes ARID1A-Mutated Cancers to PARP Inhibitors. [PDF]

open access: yesCancer Res, 2023
Yu ZC   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy